Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,466.6
-5.0 (-0.20%)

 

  • STI Straits Times Index
    2,466.6
    -5.0 (-0.20%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,504.8
    0.9 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,459.0
    183.5 (0.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,218.1
    -6.3 (-0.20%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,185.1
    -354.0 (-1.50%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,870.0
    -9.1 (-0.19%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,275.6M
  • Value: 1,346.5M
  • Rise: 149
  • Fall: 147
  • Unch: 483

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.146+0.002
HPH Trust USD0.164+0.018
Beverly JCG0.001-0.001
Jiutian Chemical0.048-0.002
Singtel2.120+0.020
CapitaMall Trust1.930-0.060
ThaiBev0.605+0.010
Keppel Corp4.450+0.150
Golden Agri-Res0.142+0.001
Rex Intl0.141-0.001

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EQUILLIUM INC EQUILLIUM INC
Updated on 29 Sep 2020 (End of trading day)
Last (USD): 5.740 Change: +0.110 High: 5.780 Remarks: -
Change (%): +1.95 Low: 5.520
Open 5.590 Yesterday's Close 5.63
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 157,213 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.05509 Trailing EPS (USD) e -1.14901 NAV (USD) b 1.2765
PE a - Trailing PE f - Price / NAV b 4.4967
Dividend (USD) d - Cash In Hand (USD) g 0.9926 Issued & Paid-up Shares c 24,263,400
Dividend Yield (%) d - Price / Cash In Hand g 5.783 Treasury Shares h -
Market Cap (M) 139.272 Enterprise Value (M) 106.476
Piotroski F Score 0 Exchange Code EQ Par Value ( $ ) n.a.
52 Weeks Volatility (%) 180.15 Free Float (%) 33.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 05 Oct 2018.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EQUILLIUM INC NASDAQ 139.272 - - 4.4967 -
Industry Biotechnology NASDAQ 2,734.308 685.885 6455.431 6.8337 0.648
Local Peer AMGEN INC NASDAQ 145,427.820 18.545 19.924 13.6437 2.359
Local Peer GILEAD SCIENCES INC NASDAQ 77,856.012 14.455 - 4.3189 4.098
Local Peer VERTEX PHARMACEUTICAL NASDAQ 70,406.835 59.829 33.837 9.3636 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,027.498 28.844 20.455 6.7379 -
Local Peer ILLUMINA INC NASDAQ 44,712.980 44.624 64.521 9.7990 -
Local Peer BIOGEN INC NASDAQ 44,699.676 7.591 7.542 3.9527 -
Local Peer SEATTLE GENETICS INC NASDAQ 33,226.467 - - 18.3159 -
Local Peer MODERNA INC NASDAQ 27,826.275 - - 9.4426 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 25,444.350 - - 10.0322 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,648.196 10.252 29.132 2.3495 -
Local Peer IMMUNOMEDICS INC NASDAQ 19,706.134 - - 33.2139 -
Local Peer INCYTE CORPORATION NASDAQ 19,120.854 42.785 - 8.1553 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), VAXCYTE INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALLOVIR INC (NASDAQ), UNIQURE N.V. (NASDAQ), CYTOKINETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), VIELA BIO INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ARVINAS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), PERSONALIS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AKOUOS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), NANTKWEST INC (NASDAQ), VAXART INC (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), GERON CORP (NASDAQ), HUMANIGEN INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ATRECA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ARDELYX INC (NASDAQ), IVERIC BIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MERUS B V (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMV INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), VERASTEM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ADURO BIOTECH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), BELLUS HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOVIE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), GEOVAX LABS INC (NASDAQ)
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer CSL ASX 130,573.807 41.633 41.633 13.7727 1.023
Global Peer WUXI BIO HKEx 253,456.475 220.479 176.023 16.9673 -
Global Peer BEIGENE HKEx 198,991.834 - - 10.1230 -
Global Peer SINO BIOPHARM HKEx 159,284.744 51.897 57.918 4.6133 0.629
Global Peer ZAI LAB-SB HKEx 110,174.567 - - - -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,522.184 101.325 32.426 4.6064 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 24,323.301 - - 3.3268 -
Global Peer 3SBIO HKEx 22,179.756 20.088 14.772 1.8961 -
Other Global Peers MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), KINTOR PHARMA-B (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), NANOVIRICIDES INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), ANTEOTECH LIMITED (ASX), AIM IMMUNOTECH INC (NYSE American), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), BIONOMICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CT ENTERPRISE (HKEx), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), RHINOMED LIMITED (ASX), Suntar Eco-City (SGX), BIOSINO BIO-TEC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), REGENT PACIFIC (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.130
+2.32 %
10 Days --0.580
-9.18 %
20 Days -+0.410
+7.69 %
Medium Term Return 3 Months -+2.940
+105.00 %
6 Months -+3.260
+131.45 %
1 Year -+2.040
+55.14 %
Annualised Return Annualised --
+55.14 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.200 - 27.050 Change From 1 Year Low +3.540 % Change From 1 Year Low (%) +160.91
Change From 1 Year High -21.310 % Change From 1 Year High (%) -78.78
2 Years Range 2.200 - 27.050 Change From 2 Years Low +3.540 % Change From 2 Years Low (%) +160.91
Change From 2 Years High -21.310 % Change From 2 Years High (%) -78.78
5 Years Range 2.200 - 27.050 Change From 5 Years Low +3.540 % Change From 5 Years Low (%) +160.91
Change From 5 Years High -21.310 % Change From 5 Years High (%) -78.78
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Equillium, Inc. is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
29 Sep 2020 5.590 5.780 5.520 5.740 157,213 -
28 Sep 2020 5.820 5.821 5.510 5.630 139,510 -
25 Sep 2020 5.610 5.860 5.500 5.750 134,084 -
24 Sep 2020 5.450 5.751 5.100 5.600 179,545 -
23 Sep 2020 6.270 6.510 5.590 5.610 350,933 -
22 Sep 2020 6.670 6.690 6.180 6.310 321,199 -
21 Sep 2020 6.420 6.820 6.100 6.780 341,631 -
18 Sep 2020 6.330 6.900 6.160 6.410 678,025 -
17 Sep 2020 6.300 6.529 6.110 6.370 316,426 -
16 Sep 2020 6.080 6.320 5.800 6.320 571,848 -
15 Sep 2020 6.010 7.500 5.910 6.010 3,966,329 -
14 Sep 2020 5.570 6.110 5.410 5.720 456,640 -
11 Sep 2020 5.160 5.790 5.060 5.560 372,449 -
10 Sep 2020 5.250 5.360 5.020 5.120 120,717 -
09 Sep 2020 5.270 5.400 4.920 5.250 274,292 -
08 Sep 2020 4.980 5.490 4.800 5.160 282,579 -
04 Sep 2020 5.300 5.335 4.700 5.060 394,294 -
03 Sep 2020 5.360 5.570 5.120 5.180 374,362 -
02 Sep 2020 5.390 5.530 5.230 5.330 297,194 -
01 Sep 2020 5.860 5.860 5.250 5.460 438,880 -
31 Aug 2020 6.020 6.080 5.770 5.890 419,742 -
28 Aug 2020 6.000 6.090 5.810 6.080 577,297 -
Summary
Current 2 Weeks
(16 Sep 2020 to 29 Sep 2020)
6.080 6.900 5.100 5.740 3,190,414 -
Previous 2 Weeks
(01 Sep 2020 to 15 Sep 2020)
5.860 6.900 5.100 6.010 6,977,736 -
4 Weeks from
(04 Aug 2020 to 31 Aug 2020)
10.010 10.900 5.100 5.890 14,374,603 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.